期刊文献+

艰难梭菌感染的临床诊断与治疗研究进展 被引量:2

The clinical diagnosis and therapy of Clostridium difficile infection: progress review
原文传递
导出
摘要 艰难梭菌感染可引起相关腹泻,且在住院患者中的发病率不断升高。根据腹泻的程度不同,艰难梭菌相关腹泻可分为轻、中、重和暴发型4型,临床诊断除了血常规外,毒素鉴定与内镜诊断也是重要的辅助检查手段。目前在临床治疗中仍以甲硝唑或万古霉素等抗生素进行药物治疗,可通过益生菌来调节肠道菌群实现艰难梭菌相关腹泻的预防。 Clostridium difficile infection can cause diarrhea, and the incidence has been increasing among inpatients. There are 4 types of Clostridium difficile associated diarrhea (CDAD) according to the symptom severity, including light, moderate, severe and fulmi- nant diarrhea. The blood test is the conventional diagnostic method, beside this, identification of toxin A and B and endoscopic observa- tion are important supplementary tests used widely. Currently, metronidazole and vancomycin are still used in clinical treatment of the dis- ease, and probiotics are applied to regulate the balance of intestinal flora for the purpose of CDAD prevention.
出处 《中国微生态学杂志》 CAS CSCD 2013年第8期972-974,共3页 Chinese Journal of Microecology
基金 国家自然基金资助项目(31200031)
关键词 艰难梭菌感染 腹泻 临床诊断 治疗 Clostridium difficile infection Diarrhea Clinical diagnosis Therapy
  • 相关文献

参考文献20

  • 1Poutanen SM, Simor AE. Clostddium dlfticile--associated diarrhea in adults[J]. Can Med Assoc J,2004,171 (1) :51-58.
  • 2Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings [ J ]. Expert Rev Gastroenterol Hepato1,2010,4 ( 4 ) :409 -416.
  • 3Oake N,Taljaard M, Van Walraven C, et al. The effect of hospital-ac- quired Clostridium difficile infection on in-hospital mortality [ J ]. Arch Intern Med ,2010,170 ( 20 ) : 1804-1810.
  • 4Gasperino J, Garala M, Cohen HW, et al. Investigation of critical care unit utilization and mortality in patients infected with Clostridium diffi- cile[J]. J Crit Care,2010,25(2):282-286.
  • 5Kelly CP, Lamont JT. Clostridium difficile--more difficult than ever [ J]. N Engl J Med,2008,359 ( 18 ) : 1932-1940.
  • 6Mcdonda!.d LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile[J]. N Engl JMed ,2005,353 ( 23 ) :2433-2441.
  • 7Indra A, Huhulescu S, Fieldhr A, et al. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009 [ J ]. Euro Surveill, 2009, 14(17) :19186.
  • 8黄海辉.应重视艰难梭菌感染的检测[J].中国感染与化疗杂志,2011,11(6):424-425. 被引量:2
  • 9Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis [ J ]. N Engl J Med,1994,330(24) :257-262.
  • 10Rodrigue-Palacios A, Orgmann S, Kline TR, et al. Clostridium difficile in foods and animals:history and measures to reduce exposure [ J ]. An- imal Health Res Rev ,2012, doi: 10. 1017/S1466252312000229,1-19.

二级参考文献25

  • 1Lynne V McFarland.Systematic review and meta-analysis of Saccharomyces boulardii in adult patients[J].World Journal of Gastroenterology,2010,16(18):2202-2222. 被引量:64
  • 2徐国良,潘令嘉,孙勇,张秀荣.肠粘膜细菌培养诊断抗生素相关性腹泻的价值[J].现代消化及介入诊疗,1999,4(1):37-38. 被引量:16
  • 3WEHKAM P J, HARDER J, WEICHENTH M M, el al. Inducible and constitutive β-defensins are diferentially expressed in Crohn's disease and ulcerative colitis[J]. Inflam Bowel Dis,2003,9(4) :215-223.
  • 4ZHOU J S, GOPAL P K, GILL H S. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus ( HN001 ) , Lactobacillus acidophilus (HN017) and Bifidobacterium lactis ( HN019 ) do not degrade gpstric mucin in vitro[ J]. Int J Food Microbiol,2002,63 (6) :81-90.
  • 5WEHKAM P J, SCHWIND B. Innateimmunity and olonic inflammation : enhanced expression of epithelial alpha-de[ J]. Dig Dis Sci ,2002, 47 (6) : 1349-1355.
  • 6MACPHERSON A J,HUNZIKER L,McCOY K,et al. IgA responds in the intestinal mucosa against pathogenic and non-pathogenic microorganisms[ J]. Microbes Infect,2001,3 (12) : 1021-1035.
  • 7MacPHERSON A J, UHR T. Induction of protective IgA by intestinal dendritic cells canting commensal bacteria [ J ]. Science, 2004,303 (5664) :1662-1665.
  • 8UREN T K,JOHANSEN F E,WIJBURG O L,et al. Role of the polymeric Ig receptor in mueosal B cell homeostasis[ J]. J Immunol,2003, 170(5) :2531-2539.
  • 9Dial S, Delaney JA, Barkun AN, et al. Use of gastric acidsuppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J]. JAMA, 2005, 294(23):2989-2995.
  • 10Miller MA, Gravel D, Mulvey M, et al. Surveillance for noso- comial Clostridiurn difficile associated diarrhea (N CDAD) within acute-care hospitals in Canada: results of the 2005 nos-ocomial infections surveillance program (CNISP) study shows escalating mortality[C]. In: Proceedings of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America: March 18 21, 2006; Chicago, IL.

共引文献36

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部